89-016-715

apolipoprotein A-IV, Mouse, Purified MaxPab™ Polyclonal Antibody, Abnova™

Manufacturer: Abnova Corporation

Select a Size

Pack Size SKU Availability Price
Each of 1 89-016-715-Each-of-1 In Stock ₹ 46,458.00

89-016-715 - Each of 1

₹ 46,458.00

In Stock

Quantity

1

Base Price: ₹ 46,458.00

GST (18%): ₹ 8,362.44

Total Price: ₹ 54,820.44

Antigen

apolipoprotein A-IV

Classification

Polyclonal

Description

Mouse polyclonal antibody raised against a full-length human APOA4 protein.

Gene

APOA4

Gene Alias

MGC142154/MGC142156

Host Species

Mouse

Purification Method

Affinity Purified

Regulatory Status

RUO

Gene ID (Entrez)

337

Content And Storage

Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Isotype

IgG

Applications

Immunohistochemistry (PFA fixed), Western Blot

Conjugate

Unconjugated

Formulation

PBS with no preservative; pH 7.4

Gene Accession No.

BC074764.2

Gene Symbols

APOA4

Immunogen

APOA4 (AAH74764.1, 1 a.a. ∼ 396 a.a) full-length human protein.

Quantity

50 μg

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Related Products

Img

Abnova Corporation

89-016-716

--

Img

Abnova Corporation

89-016-710

--

Img

Abnova Corporation

89-016-785

--

Img

Abnova Corporation

89-016-777

--

Img

Abnova Corporation

89-016-713

--

Img

Abnova Corporation

89-016-622

--

Img

Abnova Corporation

89-016-792

--

Img

Abnova Corporation

89-016-733

--

Description

  • Apoliprotein (apo) A-IV gene contains 3 exons separated by two introns
  • A sequence polymorphism has been identified in the 3'UTR of the third exon
  • The primary translation product is a 396-residue preprotein which after proteolytic processing is secreted its primary site of synthesis, the intestine, in association with chylomicron particles
  • Although its precise function is not known, apo A-IV is a potent activator of lecithin-cholesterol acyltransferase in vitro
  • [provided by RefSeq] Sequence: MFLKAVVLTLALVAVAGARAEVSADQVATVMWDYFSQLSNNAKEAVEHLQKSELTQQLNALFQDKLGEVNTYAGDLQKKLVPFATELHERLAKDSEKLKEEIGKELEELRARLLPHANEVSQKIGDNLRELQQRLEPYADQLRTQVNTQAEQLRRQLTPYAQRMERVLRENADSLQASLRPHADELKAKIDQNVEELKGRLTPYADEFKVKIDQTVEELRRSLAPYAQDTQEKLNHQLEGLTFQMKKNAEELKARISASAEELRQRLAPLAEDVRGNLRGNTEGLQKSLAELGGHLDQQVEEFRRRVEPYGENFNKALVQQMEQLRQKLGPHAGDVEGHLSFLEKDLRDKVNSFFSTFKEKESQDKTLSLPELEQQQEQQQEQQQEQVQMLAPLES